|
Press Releases |
|
 |
|
Tuesday, August 26, 2025 |
|
Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation |
Essex Bio-Technology Limited ('Essex' and its subsidiary the 'Group', Stock Code: 1061.HK), a leading biologic Group that develops, manufactures and commercialises genetically engineered therapeutic recombinant bovine basic fibroblast growth factor ('rb-bFGF'), today announced its interim results for the six months ended 30 June 2025 ('the period under review'). more info >> |
|
Wednesday, August 13, 2025 |
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration |
Essex Bio-Technology Limited ('Essex' or the 'Group', Stock Code: 1061.HK) is pleased to announce that a Biologics License Application ('BLA') for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal antibody injection, has recently been accepted by the Centre for Drug Evaluation ('CDE') of the National Medical Products Administration ('NMPA') in China. The product is jointly developed by the Group and Shanghai Henlius Biotech, Inc. ('Henlius', Stock Code: 2696.HK) for the treatment of wet age-related macular degeneration ('wet-AMD') in China. more info >> |
|
Friday, July 25, 2025 |
|
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China |
Essex Bio-Technology Limited ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that(Zhuhai Essex Bio-Pharmaceutical Company Limited), an indirect wholly-owned subsidiary, has received approval from (National Medical Products Administration) for the registration and commercialisation of the multi-dose Diquafosol Sodium Eye Drops in the PRC. more info >> |
|
Monday, March 18, 2024 |
|
Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1% |
Essex Bio-Technology Limited ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2023. more info >> |
|
Wednesday, August 16, 2023 |
|
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22% |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2023 ("the period under review"). more info >> |
|
Wednesday, July 26, 2023 |
|
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that a phase 1/2 clinical trial of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. more info >> |
|
Friday, April 14, 2023 |
|
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore |
Essex Bio-Technology Ltd. ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that its wholly-owned subsidiary, Majeton Pte. Ltd. ("Majeton"), has entered into an exclusive Distribution Agreement with Osteopore Limited ("Osteopore") to promote and sell Osteopore's dental and oral maxillofacial products ("Products") in Singapore. more info >> |
|
Tuesday, April 11, 2023 |
|
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China |
Essex Bio-Technology Ltd. ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that its wholly-owned subsidiary, Essex Medipharma (Zhuhai) Co., Ltd. ("Essex Medipharma"), has entered into an Agency Agreement ("Agency Agreement") with Gunze Medical Devices (Shenzhen) Ltd. more info >> |
|
Wednesday, March 8, 2023 |
|
Essex Bio-Technology Announces 2022 Annual Financial Results |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2022. more info >> |
|
Wednesday, February 22, 2023 |
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited ("Essex Bio-Investment") and Zhuhai Essex Bio-Pharmaceutical Co. Ltd ("Zhuhai Essex") more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
NEC Security to Provide Cybersecurity Services for GREENxEXPO 2027 (International Horticultural Expo 2027,Yokohama, Japan)
Oct 3, 2025 23:01 JST
|
|
|
Honda Announces New Investment in Motorcycle Plant in Brazil
Oct 3, 2025 22:36 JST
|
|
|
uSmart Securities Initiates Coverage on Sunrise New Energy (EPOW.US) with a "Recommended" Rating and $10.07 Price Target
Oct 3, 2025 21:30 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Thermal Systems Has Launched "ETI-W"
Oct 3, 2025 22:15 JST
|
|
|
VirPoint.com Unveils 2023 Financial Results and Launches AI Trading Suite at London Investor Summit
Oct 3, 2025 21:00 HKT/SGT
|
|
|
Fujitsu expands strategic collaboration with NVIDIA to deliver full-stack AI infrastructure
Oct 3, 2025 21:24 JST
|
|
|
3D printed homes to unlock affordable living thanks to Japan-Queensland deal
Oct 3, 2025 19:00 HKT/SGT
|
|
|
Nomad eSIM x beIN SPORTS: Connecting Fans during Race Weekend
Oct 3, 2025 17:40 HKT/SGT
|
|
|
MHI Starts a Study on Optimizing the Decarbonization Value Chain Using Green Hydrogen and Ammonia Exported from India
Oct 3, 2025 18:34 JST
|
|
|
Eisai Highlights Breadth of Oncology Research at ESMO 2025
Oct 3, 2025 18:01 JST
|
|
|
Mazda Ranked Highest in J.D. Power 2025 Japan Sales Satisfaction Index Study for Second Consecutive Year in Mass Market Domestic Brands Segment
Oct 3, 2025 17:38 JST
|
|
|
MHI and QST Complete the First Outer Vertical Target of the Divertor for the ITER Project in Southern France
Oct 3, 2025 16:57 JST
|
|
|
MHI Signs Memorandum of Agreement with University of the Philippines to Consider Decarbonization Strategies in the Philippines
Oct 3, 2025 16:30 JST
|
|
|
Transnusa Launches Maiden Flight From Manado to Shenzhen
Oct 3, 2025 09:32 HKT/SGT
|
|
|
Sharp and ESI Asia Pacific partner to pioneer zinc-air flow battery technology in Queensland, Australia
Oct 3, 2025 08:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|